Selective photosensitizer localization in the human endometrium after intrauterine application of 5-aminolevulinic acid. 1996

M K Fehr, and P Wyss, and B J Tromberg, and T Krasieva, and P J DiSaia, and F Lin, and Y Tadir
Beckman Laser Institute and Medical Clinic, University of California, Irvine 92715, USA.

OBJECTIVE Our purpose was twofold: to determine the distribution of the endogenous photosensitizer protoporphyrin IX in the uterus and to ascertain the time interval leading to maximal endometrial fluorescence after intrauterine instillation of 5-aminolevulinic acid. METHODS One milliliter of a 400 mg/ml 5-aminolevulinic acid-Hyskon solution was instilled into the uterine cavity of 27 women before hysterectomy. On frozen sections of uterine samples 5-aminolevulinic acid-induced fluorescence was measured with fluorescence microscopy. RESULTS 5-Aminolevulinic acid-induced fluorescence could first be detected in the superficial endometrial glands 75 minutes after drug injection. In the endometrial gland stumps fluorescence intensity peaked 4 to 8 hours after 5-aminolevulinic acid instillation and was > 48 times higher than in the underlying myometrium. CONCLUSIONS Fluorescence in the endometrial glands suggests that selective photodynamic destruction of the endometrium may be possible 4 to 8 hours after intrauterine 5-aminolevulinic acid instillation.

UI MeSH Term Description Entries
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D011524 Protoporphyrins Porphyrins with four methyl, two vinyl, and two propionic acid side chains attached to the pyrrole rings. Protoporphyrin IX occurs in hemoglobin, myoglobin, and most of the cytochromes.
D004717 Endometrium The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo. Endometria
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000622 Aminolevulinic Acid A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. 5-Amino Levulinic Acid,5-Aminolaevulinate,5-Aminolevulinate,Aminolevulinic Acid Hydrochloride,Delta-Aminolevulinic Acid,Levulan,5 Amino Levulinic Acid,5 Aminolaevulinate,5 Aminolevulinate,Acid Hydrochloride, Aminolevulinic,Acid, 5-Amino Levulinic,Acid, Aminolevulinic,Acid, Delta-Aminolevulinic,Delta Aminolevulinic Acid,Hydrochloride, Aminolevulinic Acid,Levulinic Acid, 5-Amino
D017319 Photosensitizing Agents Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. Photosensitizer,Photosensitizers,Photosensitizing Agent,Photosensitizing Effect,Photosensitizing Effects,Agent, Photosensitizing,Agents, Photosensitizing,Effect, Photosensitizing,Effects, Photosensitizing

Related Publications

M K Fehr, and P Wyss, and B J Tromberg, and T Krasieva, and P J DiSaia, and F Lin, and Y Tadir
March 1996, American journal of obstetrics and gynecology,
M K Fehr, and P Wyss, and B J Tromberg, and T Krasieva, and P J DiSaia, and F Lin, and Y Tadir
May 1993, Photochemistry and photobiology,
M K Fehr, and P Wyss, and B J Tromberg, and T Krasieva, and P J DiSaia, and F Lin, and Y Tadir
November 1999, American journal of veterinary research,
M K Fehr, and P Wyss, and B J Tromberg, and T Krasieva, and P J DiSaia, and F Lin, and Y Tadir
January 1996, Journal of the Society for Gynecologic Investigation,
M K Fehr, and P Wyss, and B J Tromberg, and T Krasieva, and P J DiSaia, and F Lin, and Y Tadir
December 1995, American journal of obstetrics and gynecology,
M K Fehr, and P Wyss, and B J Tromberg, and T Krasieva, and P J DiSaia, and F Lin, and Y Tadir
November 1998, The Journal of the American Association of Gynecologic Laparoscopists,
M K Fehr, and P Wyss, and B J Tromberg, and T Krasieva, and P J DiSaia, and F Lin, and Y Tadir
January 1996, Lasers in surgery and medicine,
M K Fehr, and P Wyss, and B J Tromberg, and T Krasieva, and P J DiSaia, and F Lin, and Y Tadir
November 1995, Photochemistry and photobiology,
M K Fehr, and P Wyss, and B J Tromberg, and T Krasieva, and P J DiSaia, and F Lin, and Y Tadir
April 2003, Journal of hepatology,
M K Fehr, and P Wyss, and B J Tromberg, and T Krasieva, and P J DiSaia, and F Lin, and Y Tadir
January 2006, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer,
Copied contents to your clipboard!